Induction of Tolerance by IL-10-Treated Dendritic Cells

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4772-4780

  Steinbrink, Kerstin ^a   Wölfl, Matthias ^a   Jonuleit, Helmut ^a   Knop, Jürgen ^a   Enk, Alexander H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; EPITOPE; GROWTH INHIBITOR; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; MONOCLONAL ANTIBODY;

ANTIGEN PRESENTATION; ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CLONAL ANERGY; CYTOLOGY; DENDRITIC CELL; DOSE RESPONSE; DRUG EFFECT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD3; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CLONAL ANERGY; CLONE CELLS; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GROWTH INHIBITORS; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; ISOANTIGENS; LYMPHOCYTE ACTIVATION; UP-REGULATION;

EID: 0031573204     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Hoefsmit, E. C. M., A. M. Duijvestin, and W. A. Kamperdijk. 1982. Relation between Langerhans cells, veiled cells, and interdigitating cells. Immunobiology 161:255.
3. Austyn, J. M., J. W. Kupiec-Weglinski, D. F. Hankins, and P. J. Morris. 1988. Migration patterns of dendritic cells in the mouse: homing to T-cell-dependent areas of spleen and binding within marginal zones. J. Exp. Med. 166:646.
4. Larsen, C. P., R. M. Steinman, M. D. Witmer-Pack, D. F. Hankins, P. J. Morris, and J. M. Austyn. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172:1483.
5. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526.
6. Steinman, R. M., and J. W. Young. 1991. Signals arising from antigen-presenting cells. Curr. Opin. Immunol. 3:361.
7. + T lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest. 90:229.
8. Caux, C., C. Dezutter-Dambuyant, D. Schmidt, and J. Banchereau. 1992. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
9. Romani, N., S. Gruner, D. Brang, E. Kämpken, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
10. + progenitors in human bone marrow. J. Immunol. 149:2681.
11. Santiago-Schwarz F., E. Belilos, B. Diamond, and S. E. Carsons. 1992. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells and macrophages. J. Leukocyte Biol. 52:274.
12. + dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588.
13. de Waal Malefyt, R. W., H. Yssel, M. G. Roncarolo, H. Spits, and J. E. de Fries. 1992. Interleukin-10. Curr. Opin. Immunol. 4:314.
14. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cells. IV. Th2 clones secret a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
15. Benjamin, D., T. K. Knohloch, and M. A. Dayton. 1992. Human B-cell interleukin-10: B cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289.
16. Enk, A. H., and S. I. Katz. 1992. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149:92.
17. Moore, K. W., A. O'Garra, R. W. de Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
18. Hsu, D. H., K. W. Oore, and H. Spits. 1992. Differential effects of interleukin-4 and -10 on interleukin-2-induced interteron-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4:563.
19. Fioremino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
20. Willems, F., A. Marchant, J.-A. Delville, C. Gérard, A. Delvaux, T. Velu, M. de Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular molecule-1 expression on human monocytes. Eur. J. Immunol. 24:1007.
21. de Waal Malefyt, R. W., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-capacity of monocytes via downregulalion of class II major histocompatibility complex expression. J. Exp. Med. 174: 915.
22. de Waal Malefyt, R., J. Abrams, B. Bennet, C. G. Figdor, and J. E. de Fries. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced hy monocytes. J. Exp. Med. 174:1209.
23. Fiorentino, D. F., A. Zlotnik, T. R. Mosman, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
24. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685:713.
25. Beissert, S., J. Hosoi, S. Grabbe, A. Asahina, and R. D. Granstein. 1995. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol. 154:1280.
26. Caux, C., C. Massacier, B. Vanbervilet, C. Barthelmy, Y.-J. Liu, and J. Banchereau. 1994. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 8:1177.
27. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10. J. Immunol. 151:2390.
28. Peguet-Navarro, J., C. Moulon, C. Caux, C. Dalbiez-Gauthier, J. Banchereau, and D. Schmitt. 1994. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur. J. Immunol. 24:884.
29. Lamb, J. R., D. D. Eckels, P. Lake, J. N. Woody, and N. Green. 1982. Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Narure 300:66.
30. Zhou, L.-J., and T. F. Tedder. 1996. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821.
31. Ding, L., and E. Shevach. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:3133.
32. Macatonia, S. E., T. M. Doherty, S. C. Knight, and A. O'Garra. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J. Immunol. 150:3755.
33. Koch, F., C. Heufler, E. Kämpken, D. Schneeweiss, G. Böck, and G. Schuler. 1990. TNF-α maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to GM-CSF, without inducing their functional maturation J. Immunol. 171:159.
34. Ding, L., P. S. Linsley, L.-Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
35. Chang, C.-H., M. Furue, and K. Tamaki. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Eur. J. Immunol. 25:394.
36. Mitra, R. S., T. A. Judge, F. O. Nestle, L. A. Turka, and B. J. Nickoloff. 1995. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. J. Immunol. 154:2668.
37. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1.
38. Dummer, W., B. C. Bastian, N. Ernst, C. Schänzle, A. Schwaaf, and E.-B. Bröcker. 1996. Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int. J. Cancer 66: 607.
39. Lattime, E., M. Mastrangelo, O. Bagasra, W. Li, and D. Berd. 1995. Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol. Immunother. 41:151.
40. Kim, J., R. L. Modlin, R. L. Moy, S. M. Dubinet, T. McHugh, B. J. Nickoloff, and K. Uyemura. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response. J. Immunol. 155:2240.
41. Gastl, G. A., J. S. Abrams, D. M. Nanus, R. Osterkamp, J. Silver, F. Liu, M. Chen, A. P. Albino, and N. Bander. 1993. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55:96.
42. Dummer, W., J. C. Becker, A. Schwaaf, M. Leverkus, T. Moll, and E.-B. Bröcker. 1995. Elevated serum levels of interleukin-10 in patients with metastatic melanoma. Melanoma Res. 5:67.